$0.83
1.06% today
Nasdaq, Sep 30, 04:38 pm CET
ISIN
US89846A2078
Symbol
SCNX

Trxade Group Inc Stock price

$0.84
-0.14 13.99% 1M
-0.60 41.76% 6M
-5.21 86.14% YTD
-6.74 88.94% 1Y
-9.63 91.99% 3Y
-56.54 98.54% 5Y
-55.23 98.50% 10Y
-4,499.17 99.98% 20Y
Nasdaq, Closing price Mon, Sep 29 2025
-0.01 0.84%
ISIN
US89846A2078
Symbol
SCNX

Key metrics

Basic
Market capitalization
$17.4m
Enterprise Value
$21.5m
Net debt
$4.1m
Cash
$20.0k
Shares outstanding
16.1m
Valuation (TTM | estimate)
P/E
negative | -
P/S
133.9 | -
EV/Sales
165.3 | -
EV/FCF
negative
P/B
0.2
Dividends
DPS
$8.96
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
361.5% | -33.1%
Increased
1 Year
Financials (TTM | estimate)
Revenue
$130.0k | -
EBITDA
$-16.4m | -
EBIT
$-16.4m | -
Net Income
$-20.1m | -
Free Cash Flow
$-13.3m
Growth (TTM | estimate)
Revenue
-97.1% | -
EBITDA
14.6% | -
EBIT
14.2% | -
Net Income
-582.7% | -
Free Cash Flow
-35.7%
Margin (TTM | estimate)
Gross
5.8%
EBITDA
-12,760.4% | -
EBIT
-12,825.0%
Net
-15,702.7% | -
Free Cash Flow
-10,374.6%
Financial Health
Equity Ratio
75.4%
Return on Equity
11.5%
ROCE
-17.0%
ROIC
-15.9%
Debt/Equity
0.1
More
EPS
$-1.4
FCF per Share
$-0.8
Short interest
1.6%
Employees
-
Rev per Employee
-
Show more

Is Trxade Group Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

Trxade Group Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Trxade Group Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Trxade Group Inc forecast:

Buy
86%
Hold
14%

Financial data from Trxade Group Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
0.13 0.13
97% 97%
100%
- Direct Costs 0.12 0.12
98% 98%
92%
0.01 0.01
102% 102%
8%
- Selling and Administrative Expenses 13 13
5% 5%
9,838%
- Research and Development Expense 3.65 3.65
-
2,808%
-16 -16
15% 15%
-12,585%
- Depreciation and Amortization 0.08 0.08
700% 700%
62%
EBIT (Operating Income) EBIT -16 -16
14% 14%
-12,647%
Net Profit -20 -20
583% 583%
-15,485%

In millions USD.

Don't miss a Thing! We will send you all news about Trxade Group Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Trxade Group Inc Stock News

Neutral
GlobeNewsWire
14 days ago
Arbli ™ is the first and only ready-to-use liquid formulation of losartan, eliminating the need for compounding while offering reduced dosing volume and extended room-temperature shelf life
Neutral
GlobeNewsWire
about 2 months ago
Commack, NY, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Scienture Holdings, Inc. (Nasdaq: SCNX) (“Scienture” or the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, today announ...
Neutral
GlobeNewsWire
about 2 months ago
COMMACK, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, is pleased to announce the shipment of launc...
More Trxade Group Inc News

Company Profile

Trxade Group, Inc. owns and operates a business-to-business Web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; and Other segments. The company operates a Web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a Web-based pharmaceutical marketplace; InventoryRx.com, a Web-based pharmaceutical exchange platform; Pharmabayonline that provides proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis to the United States-based independent pharmacies and pharmaceutical databases; and RxGuru, a desktop application, which provides product information. The company also operates a retail specialty pharmacy. In addition, it operates Delivmeds.com, a consumer-based app to provide delivery of pharmaceutical products; and Trxademso.com to assist independent retail pharmacies on pricing, distribution, and logistics. Trxade Group, Inc. is based in Land O'Lakes, Florida.

Head office United States
CEO Surendra Ajjarapu
Founded 2005
Website www.trxadehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today